Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

248 ta ish

Ish: siRNA-based strategies to combat drug resistance in gastric cancer

  1. Clinical Pharmacokinetics of Doxorubicin

    P A Speth, Q.G.C.M. van Hoesel, C. Haanen

    Sharh maqola19882 iqtibos
    ABI

  2. Targeting EZH2 in cancer

    Kimberly H. Kim, Charles W.M. Roberts

    Sharh maqola20162 iqtibos
    ABI

  3. LncRNA UCA1 in anti-cancer drug resistance

    Haohao Wang, Zhonghai Guan, Kuifeng He +3

    Sharh maqola20172 iqtibos
    ABI

  4. Epithelial Mesenchymal Transition in Tumor Metastasis

    Vivek Mittal

    Sharh maqola20182 iqtibos
    ABI

  5. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway

    Xing Zhang, Sen Wang, Haixiao Wang +8

    Maqola20192 iqtibos
    ABI

  6. Noncoding RNAs in gastric cancer: implications for drug resistance

    Ling Wei, Jujie Sun, Nasha Zhang +7

    Sharh maqola20202 iqtibos
    ABI

  7. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway

    Qingqiang Dai, Tianqi Zhang, Jiaomeng Pan +1

    Maqola20202 iqtibos
    ABI

  8. EZH2: a novel target for cancer treatment

    Ran Duan, Wenfang Du, Weijian Guo

    Sharh maqola20202 iqtibos
    ABI

  9. Pepsinogen C expression–related lncRNA/circRNA/mRNA profile and its co-mediated ceRNA network in gastric cancer

    Lirong Yan, Han-xi Ding, Shixuan Shen +3

    Maqola20212 iqtibos
    ABI

  10. Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance

    Xiaolin Wang, Jiahui Zhang, Guozhen Cao +3

    Sharh maqola20222 iqtibos
    ABI

  11. Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro

    Parsa Aliabadi, Maryam Sadri, Goli Siri +8

    Maqola20222 iqtibos
    ABI

  12. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

    Xuhui Tong, Rong Tang, Mingming Xiao +6

    Sharh maqola20222 iqtibos
    ABI

  13. FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway

    Yunjiang Zhou, Yaxin Chen, Yongwei Shi +6

    Maqola20232 iqtibos
    ABI

  14. CircRNA: A new class of targets for gastric cancer drug resistance therapy

    Ying Zheng, Zhe Li, Yao Wang +4

    Sharh maqola20232 iqtibos
    ABI

  15. Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives

    Jiahua Liu, Qihang Yuan, Hui Guo +3

    Maqola20242 iqtibos
    ABI

  16. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

    Qiang Lü, Dongquan Kou, Shenghan Lou +13

    Maqola20242 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI